Sinovac Biotech (SVA)

Add to Watchlists
Create an Alert
7.89 +0.14  +1.81% NASDAQ Dec 11, 15:54 Delayed 2m USD

Sinovac Biotech Total Liabilities (Quarterly):

115.11M for June 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Sinovac Biotech Total Liabilities (Quarterly) Chart

Export Data
Save Image
Print Image

Sinovac Biotech Historical Total Liabilities (Quarterly) Data

View and export this data going back to 2003. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2017 115.11M
Dec. 31, 2016 95.59M
Sept. 30, 2016 88.75M
June 30, 2016 69.63M
March 31, 2016 81.07M
Dec. 31, 2015 81.27M
Sept. 30, 2015 80.62M
June 30, 2015 90.25M
March 31, 2015 87.71M
Dec. 31, 2014 111.97M
Sept. 30, 2014 116.52M
June 30, 2014 105.79M
March 31, 2014 111.26M
Dec. 31, 2013 112.01M
Sept. 30, 2013 103.87M
June 30, 2013 103.82M
March 31, 2013 99.60M
Dec. 31, 2012 91.04M
Sept. 30, 2012 87.86M
June 30, 2012 86.80M
March 31, 2012 84.41M
Dec. 31, 2011 85.99M
Sept. 30, 2011 81.12M
June 30, 2011 74.80M
   
March 31, 2011 78.71M
Dec. 31, 2010 87.92M
Sept. 30, 2010 83.62M
June 30, 2010 74.03M
March 31, 2010 92.58M
Dec. 31, 2009 74.82M
Sept. 30, 2009 62.94M
June 30, 2009 61.45M
March 31, 2009 31.39M
Dec. 31, 2008 33.49M
Sept. 30, 2008 29.59M
June 30, 2008 32.06M
March 31, 2008 26.82M
Dec. 31, 2007 27.44M
Sept. 30, 2007 24.89M
June 30, 2007 20.95M
Dec. 31, 2006 17.76M
June 30, 2006 13.61M
Dec. 31, 2005 13.28M
June 30, 2005 8.598M
Dec. 31, 2004 9.983M
Sept. 30, 2004 12.52M
June 30, 2004 12.29M
Dec. 31, 2003 8.748M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Advertisement

SVA Total Liabilities (Quarterly) Benchmarks

Benchmarks
Tianyin Pharmaceutical 5.769M
China Pharma Holding 17.96M
China Health Resource 17.43M

SVA Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 69.63M Jun 2016
Maximum 116.52M Sep 2014
Average 96.99M

SVA Total Liabilities (Quarterly) Excel Add-In Codes

  • Metric Code: liabilities
  • Latest data point: =YCP("SVA", "liabilities")
  • Last 5 data points: =YCS("SVA", "liabilities", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.